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Abstract
The preparation of peptide fragments containing dehydrovaline and dehydroisoleucine moieties present in the antibiotic myxo-
valargin is reported. Peptide formation is based on a copper-mediated C–N cross-coupling protocol between an acyl amide and a
peptidic vinyl iodide. The presence of a neighboring arginine in the vinyl iodide posed a challenge with respect to the choice of the
protecting group and the reaction conditions. It was found that ornithine – a suitable precursor – is better suited than arginine for
achieving good yields for the C–N cross-coupling reaction. The optimized conditions were utilized for the synthesis of peptides 32,
33, 39 and 40 containing a neighboring ornithine as well as for the tripeptide 44 containing dehydroisoleucine with the correct
stereochemistry.
Introduction
Dehydroamino acids [1] are rare amino acids that are
constituents of many oligopeptides from microbial sources.
Typical examples are myxovalargin (1), argyrin (2) and nisin
(3, Scheme 1).
Dehydroamino acids and peptides are characterized by the pres-
ence of an olefinic double bond conjugated with the carboxyl or
peptidic carbonyl group. Besides being α,β-unsaturated acids or
amides, respectively, they can also be regarded as enamines.
Due to the lack of reactivity of the amino group as well as the
carboxylate, dehydroamino acids have hardly employed as
building blocks in peptide synthesis. Therefore, the olefinic
double bond is commonly introduced after the peptide back-
bone is assembled and typically this is achieved by elimination
when a leaving group occupies the β-position [2]. Especially
peptides containing dehydroalanine as found in argyrin (2) can
be prepared from a precursor that contains a selenide substitu-
ent in the β-position [3]. Peptides that bear the doubly branched
dehydroamino acids dehydrovaline or dehydroisoleucine, e.g.,
found in myxovalargin (1), are much more challenging to
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Scheme 1: Selected examples of oligopeptides bearing dehydroamino acid moieties: myxovalargin (1), argyrin A (2) and nisin (3) (in myxovalargin
dehydroamino acids and neighboring amino acids are numbered).
Scheme 2: The Buchwald cross-coupling reaction in the preparation of peptides containing dehydroamino acids 4.
prepare due to steric hindrance in the β-position and the issue of
regiocontrol during elimination [4,5], as β-elimination of a
tertiary alcohol group often leads to the terminal instead of the
conjugated alkene.
Principally, enamides can also be prepared by the copper-medi-
ated C–N coupling between a vinyl halide 6 and an amide 5 as
reported by Ogawa and co-workers in 1991 [6]. Later, the group
of Porco showed that copper(I) thiophencarboxylate is a suit-
able catalyst to promote this reaction in the presence of cesium
carbonate as base and N-methylpyrrolidone (NMP) as solvent
[7,8]. Buchwald et al. [9] simplified the conditions by demon-
strating that copper(I) iodide, potassium carbonate and the
ligand N,N-dimethylethylenediamine can be used instead.
Finally, Ma and co-workers [10] further modified the condi-
tions using copper(I) iodide, cesium carbonate and N,N-
dimethylglycine in 1,4-dioxane. Recently, Inoue applied this
cross-coupling protocol to the synthesis of peptides (Scheme 2)
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Scheme 3: Syntheses of vinyl iodides 10 and 11.
[11,12] as demonstrated in the total synthesis of Yaku'amide A
[13].
As part of our study on the total synthesis of myxovalargin (1),
a secondary metabolite from Myxococcus fulvus with antibacte-
rial activity [14,15], we report on copper-mediated cross-cou-
pling chemistry to create peptide fragments bearing dehydrova-
line and dehydroisoleucine. We faced difficulties to use the re-
ported conditions for the C–N cross coupling in the preparation
of myxovalargin peptide fragments mainly because of the steric
hindrance of β,β’-disubstituted dehydroamino acids created.
Additionally, the neighboring amino acid, especially arginine or
ornithine, a precursor for preparing arginine (amino acid num-
ber 9 in 1), can be made responsible. Thus, this report covers
our efforts to optimize the copper-mediated cross-coupling
reaction in the preparation of dehydroamino acid containing
peptide fragments present in myxovalargin (peptides contain-
ing amino acids 3-methylbutyric acid 1, 2, 7–9 and 11–13).
Results and Discussion
First vinyl iodide 10, representing dehydrovaline, was prepared
by an established sequence starting from alkynyl ester 8. Under
similar conditions vinyl iodide 11 which resembles dehy-
droisoleucine was obtained as a single diastereoisomer starting
from alkynyl ester 9 (Scheme 3). The stereochemistry of the
ethyl ester of 11 was determined NMR spectroscopically in-
cluding nOe experiments (see Supporting Information File 1).
Next, vinyl iodide 10 was subjected to amidation with L-alanine
methylate (resembling position 2 in myxovalargin) using the
reagent system PyAOP, HOAt, DIPEA to yield amide 12
(Table 1). Now, the stage was set to optimize the C–N coupling
conditions using amide 13 as coupling partner, the 3-methyl-
butyric acid located at the terminus of myxovalargin (1).
Under the published conditions [13] (vinyl iodide (1.5 equiv),
amide (1.0 equiv), CuI (0.6 equiv), Cs2CO3 (2.0 equiv), N,N-
dimethylethylenediamine 16 (4.05 equiv), 1,4-dioxane, 90 °C)
we did not encounter the formation of enamide 14 but instead
only the hydrolysis product 15 was isolated which might have
resulted from the presence of oxygen in the solvent. Therefore,
we decreased the temperature and only degassed 1,4-dioxane
was used in order to avoid oxidation and formation of
copper(II) which can act as a Lewis acid. These changes provi-
ded peptide 14 (Table 1, entry 1) but this result turned out not to
be reproducible. Instead, when the reaction time was extended,
only the formation of the α-ketoamide 15 was encountered
(Table 1, entry 2). Change of the solvent to THF or toluene as
well as the use of palladium catalysts [16] or the use of addi-
tives such as HMPA mainly led to substantial decomposition of
vinyl iodide 12. At room temperature only small amounts of
product were formed but the vinyl iodide was stable (Table 1,
entry 3). The presence of the ligand was essential and the choice
of other amines such as tetramethylethylendiamine (TMEDA)
(Table 1, entry 4) or piperidine-2-carboxylate did not lead to
product formation (Table 1, entry 5).
However, (rac)-trans-N,N-dimethyl-1,2-cyclohexanediamine
(17) [9] in combination with cesium carbonate or potassium
carbonate, the latter being superior to the former base, in 1,4-
dioxane provided conditions that allowed us to prepare the cou-
pling product 14 at room temperature. When raising the temper-
ature to 50 °C the desired coupling product was isolated in 35%
yield along with a substantial amount of starting vinyl iodide
(Table 1, entry 6). When N,N-dimethylethylenediamine (16)
was employed under these conditions instead, the coupling
product formed only in traces. When potassium carbonate was
exchanged by sodium carbonate the yield dropped to 25% under
the optimized conditions (Table 1, entry 8).
Next, we tested these reaction conditions for the preparation of
the other dehydrovaline bearing peptide fragment of myxo-
valargin 1 (amino acids 7–9). First, dipeptides 18–21 and
methyl esters 22 and 23 were N-acylated with vinyl iodide 10 to
yield peptidic vinyl iodides 24–29 in commonly good yields
(Scheme 4). The coupling partners 18–23 (synthesis see Sup-
porting Information File 1) all contain arginine or the precursor
amino acid ornithine and they differ in the choice of the
protecting group. These variations are important for gaining
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Table 1: Formation of amide 12 and optimization of C–N cross coupling reaction.
entry conditions 12 (equiv) 12 (% reisolated) 14 (% yield) 15 (% yield)
1 16, Cs2CO3, 16 h, 50 °C 1.5 – 31 –
2 16, Cs2CO3, 26 h, 50 °C 1.5 – 0 nd
3 16, Cs2CO3, 24 h, rt 1.5 60 ~15 0
4a TMEDA, Cs2CO3, 20 h, rt 1.5 no reaction
5a piperidine-2-carboxylate,
K2CO3, 20 h, rt
1.5 no reaction
6 17, K2CO3, 22 h, 50 °C 2.0 43 35 0
7 17, K2CO3, 20 h, 70 °C 2.0 57 35 0
8 17, Na2CO3, 20 h, 70 °C 2.0 66 25 0
aCuI (1.0 equiv) was used instead of 0.6 equiv of CuI.
Scheme 4: Preparation of vinyl iodides 24–29 (Cbz = benzyloxycarbonyl, Alloc = allyloxycarbonyl, Boc = tert-butyloxycarbonyl, Pbf = 2,2,4,6,7-
pentamethyldihydrobenzofurane-5-sulfonyl).
flexibility towards the end of the total synthesis when the guani-
dine group has either to be liberated by the removal of the
protecting groups or used for the introduction to the correspond-
ing ornithine residue.
These results demonstrate that the copper-mediated cross-cou-
pling reaction depends on the functional groups present in the
peptide containing the vinyl iodide moiety and on the chosen
protecting groups. Vinyl iodides bearing an arginine moiety
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Scheme 5: Copper-mediated C–N cross-coupling of dehydropeptides 31–33, 36, 37, and 39–41.
gave a significantly reduced yield of the desired cross-coupling
product compared to the corresponding ornithine derivatives.
Furthermore, it turned out that the Alloc and Pbf protecting
groups are not compatible for this enamide forming protocol.
The best results were obtained by using the Boc-protected
amide 30 and ornithine-containing vinyl iodides 24 and 28
(Scheme 5).
It needs to be noted that the presence of a Cbz protecting group
in dehydrooligopeptides is problematic, because it cannot be
cleaved without simultaneously reducing the acyl enamide. We
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Scheme 6: C–N coupling reaction between amide 43 and vinyl iodide 42; formation of dehydroisoleucine containing peptide 44. nOe assignments (tri-
peptide corresponds to amino acids 11–13 in myxovalargin (1)).
found that the Teoc protecting group is better suited to be re-
moved from oligoamides 39 and 40, respectively, which were
formed from amide 38 and vinyl iodides 29 and 35 (Scheme 5)
[17]. Facile removal of the Teoc group was achieved within
24 h at room temperature in quantitative yield using a 1 M solu-
tion in TBAF in THF.
With these results in hand we next coupled amide 42 with Boc-
protected valine-derived amide 43. To our delight, the coupling
proceeded in an improved yield of 48% without scrambling of
the stereochemistry of the olefinic double bond (Scheme 6). We
based the stereochemical assignment on NMR spectroscopy
which included nOe experiments.
Conclusion
In conclusion, we report on the synthesis of dehydrovaline and
dehydroisoleucine-containing oligopeptides as found in the
peptide antibiotic myxovalargin using a C–N cross-coupling ap-
proach. Substantial optimization of the reaction conditions and
the choice of the protecting group became necessary when the
dehydrovaline-containing oligopeptide based on ornithine was
synthesized. For the copper-mediated Buchwald C–N coupling
reaction, (rac)-trans-N,N-dimethyl-1,2-cyclohexandiamine was
the ligand of choice in combination with potassium carbonate as
base. In our case, the usage of Boc and Teoc protection groups
in the cross-coupling reaction gave the best results. By using the
optimized reaction conditions the dehydroisoleucine peptide
was synthesized without scrambling of stereochemistry. In
summary, we showed that the C–N coupling reaction is a pow-
erful tool to straight forwardly build-up of sterically hindered
dehydroamino acid-containing peptide fragments.
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